| Q51334897 | (2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands. |
| Q60473661 | 7-3-Chlorophenypiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione as a serotonin receptor ligands with potential antidepressant activity |
| Q28550518 | A Comparison of the Anorectic Effect and Safety of the Alpha2-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity |
| Q40594068 | ANTI-INFLAMMATORY AND ANTIOXIDANT ACTIVITY OF 8-METHOXY-1,3-DIMETHYL-2,6-DIOXO-PURIN-7-YL DERIVATIVES WITH TERMINAL CARBOXYLIC, ESTER OR AMIDE MOIETIES IN ANIMAL MODELS. |
| Q88032187 | Alpha lipoic acid protects the heart against myocardial post ischemia-reperfusion arrhythmias via KATP channel activation in isolated rat hearts |
| Q86476756 | Analgesic activity of new 8-methoxy-1,3-dimethyl-2,6-dioxo-purin-7-yl derivatives with carboxylic, ester or amide moieties |
| Q86098508 | Analgesic and anti-inflammatory activity of 7-substituted purine-2,6-diones |
| Q95444005 | Anti-inflammatory activity of lipoic acid in mice peritonitis model |
| Q48299509 | Anti-inflammatory, antioxidant, and antiparkinsonian effects of adenosine A2A receptor antagonists. |
| Q52149069 | Antiarrhythmic activity in occlusion-reperfusion model of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino} propan-2-ol and its enantiomers. |
| Q63382961 | Antiarrhythmic activity of new 2-methoxyphenylpiperazine xanthone derivatives after ischemia/reperfusion in rats |
| Q42875740 | Antiarrhythmic activity of novel S-enantiomers of pyrrolidin-2-one derivatives with adrenolytic properties |
| Q46903664 | Antiarrhythmic activity of some xanthone derivatives with β1-adrenoceptor affinities in rats. |
| Q41644207 | Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties. |
| Q84165362 | Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers |
| Q51740483 | Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one. |
| Q63382965 | Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone |
| Q28550792 | Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models |
| Q48140118 | Antidepressant-like activity of a new piperazine derivative of xanthone in the forced swim test in mice: The involvement of serotonergic system. |
| Q48886230 | Antidepressant-like activity of the phenylpiperazine pyrrolidin-2-one derivatives in mice. |
| Q63382975 | Antidepressant-like properties of (R,S)-HBK-1 and its isomers, new xanthone derivatives, in mice |
| Q57708302 | Antiparkinsonian Effects of Novel Adenosine A2A Receptor Antagonists |
| Q44349321 | Are anti-inflammatory properties of lipoic acid associated with the formation of hydrogen sulfide? |
| Q38977969 | Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands. |
| Q51473592 | Arylsulfonamide derivatives of (aryloxy)ethyl pyrrolidines and piperidines as α1-adrenergic receptor antagonist with uro-selective activity. |
| Q46526511 | Biofunctional studies of new 2-methoxyphenylpiperazine xanthone derivatives with α₁-adrenolytic properties |
| Q104478260 | Bioresearch of New 1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones |
| Q112155768 | Characterization and antidiabetic activity of salicylhydrazone Schiff base vanadium(IV) and (V) complexes |
| Q42058859 | Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats |
| Q57476499 | Correlation of Paraoxonase-1 with the Severity of Crohn's Disease |
| Q46008778 | Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity. |
| Q87772396 | Design, synthesis, anticonvulsant, and antiarrhythmic properties of novel N-Mannich base and amide derivatives of β-tetralinohydantoin |
| Q38364945 | Ergotamine and nicergoline - facts and myths |
| Q60473668 | Evaluation of anticonvulsant activity of novel pyrrolidin-2-one derivatives |
| Q39334754 | Evaluation of antidepressant-like and anxiolytic-like activity of purinedione-derivatives with affinity for adenosine A2A receptors in mice |
| Q37273493 | H3 histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice. |
| Q58554121 | HBK-17, a 5-HT Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling |
| Q38873393 | HBK-7 - A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties. |
| Q42089891 | Hypotensive effect of alpha-lipoic acid after a single administration in rats. |
| Q46022292 | In vivo anti-inflammatory activity of lipoic acid derivatives in mice. |
| Q28213292 | Investigations on the synthesis and pharmacological properties of N-substituted derivatives of 4-alkoxy-6-methyl-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones |
| Q96577629 | KD-64-A new selective A2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist-Caffeine does not reduce diet-induced obesity in mice |
| Q91798309 | KSK19 - Novel histamine H3 receptor ligand reduces body weight in diet induced obese mice |
| Q112246857 | Ligand role on insulin-mimetic properties of vanadium complexes. Structural and biological studies |
| Q45087318 | Methylprednisolone- acute spinal cord injury, benefits or risks? |
| Q41220105 | Muscle relaxants--the current position in the treatment of spasticity in orthopedics. |
| Q53099204 | PRELIMINARY EVALUATION OF CENTRAL NERVOUS SYSTEM ACTIVITY OF (E)-N-2-METHYL-3-PHENYLPROP-2-ENYL ((E)-N- α-METHYLCINNAMYL) DERIVATIVES OF SELECTED AMINOALKANOLS. |
| Q104691822 | PSB 603 - a known selective adenosine A2B receptor antagonist - has anti-inflammatory activity in mice |
| Q96603602 | Pitolisant protects mice chronically treated with corticosterone from some behavioral but not metabolic changes in corticosterone-induced depression model |
| Q44183551 | Preparation of novel derivatives of pyridothiazine-1,1-dioxide and their CNS and antioxidant properties. |
| Q47324338 | Pyrrolidin-2-one derivatives may reduce body weight in rats with diet-induced obesity |
| Q73733814 | Search for new antiarrhythmic and hypotensive compounds. Synthesis, antiarrhythmic, antihypertensive, and alpha-adrenoceptor blocking activity of novel 1-[(2-hydroxy-3-amino)]-propylpyrrolidin-2-one derivatives |
| Q63382948 | Serotonin receptors in depression and anxiety: Insights from animal studies |
| Q53393422 | Synthesis and Analgesic Activity of Annelated Xanthine Derivatives in Experimental Models in Rodents. |
| Q63382966 | Synthesis and Evaluation of Antidepressant-like Activity of Some 4-Substituted 1-(2-methoxyphenyl)Piperazine Derivatives |
| Q112135016 | Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT1A and D2 Receptors |
| Q87243955 | Synthesis and Pharmacological Activity of a New Series of 1-(1H-Indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol Analogs |
| Q58691700 | Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α/α-Adrenergic Receptor Antagonist with Potential Uroselective Profile |
| Q81277104 | Synthesis and analgesic action of N-(substituted-ethyl)pyrrole-3,4-dicarboximides |
| Q112175287 | Synthesis and antinociceptive activity of four 1 H ‐isoindolo‐1,3(2 H )‐diones |
| Q52684757 | Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents. |
| Q81255467 | Synthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and alpha-adrenolytic activity |
| Q81101075 | Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity |
| Q43202232 | Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity |
| Q43111577 | Synthesis and pharmacological evaluation of pyrrolidin-2-one derivatives as antiarrhythmic, antihypertensive and alpha-adrenolytic agents |
| Q46554559 | Synthesis and pharmacological properties of 1-[2-hydroxy-3-(4-o,m,p-halogenophenyl)- and 3-(4-m-chlorophenyl)-1-piperazinyl]propyl derivatives of amides of 7-methyl-3-phenyl-2,4-dioxo-1,2,3,4-tetrahydropyrido [2,3-d]pyrimidine-5-carboxylic acid with |
| Q46117349 | Synthesis and pharmacological properties of new derivatives of 4-alkoxy-6-methyl-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones. |
| Q28213800 | Synthesis and properties of 4-alkoxy-2-[2-hydroxy-3-(4-o,m,p-halogenoaryl-1 -piperazinyl)propyl]-6-methyl-1H-pyrrolo-[3,4-c]pyridine-1,3(2H)-diones with analgesic and sedative activities |
| Q45053748 | Synthesis and properties of N-methyl and N-phenyl derivatives of 1,4-dioxo-1,2,3,4-tetrahydropyrido[3,4-d]pyridazines. |
| Q44393286 | Synthesis and properties of tetra(hexa)hydropyrazolo [1,2-a]pyrido[3,4-d]pyridazine derivatives. |
| Q43921800 | Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity. |
| Q112155769 | Synthesis, coordination properties and biological activity of vanadium complexes with hydrazone Schiff base ligands |
| Q44495095 | Synthesis, structure and antiarrhythmic properties evaluation of new basic derivatives of 5,5-diphenylhydantoin |
| Q95512360 | THE EFFECT OF SEROTONIN 5-HT1A, 5-HT2 RECEPTOR LIGANDS, KETOPROFEN AND THEIR COMBINATION IN MODELS OF INDUCED PAIN IN MICE |
| Q112135014 | The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia |
| Q64065792 | The Significance of Lactoperoxidase System in Oral Health: Application and Efficacy in Oral Hygiene Products |
| Q41931564 | The antidepressant- and anxiolytic-like activities of new xanthone derivative with piperazine moiety in behavioral tests in mice. |
| Q48077440 | The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation |
| Q100995819 | The antidepressant-like activity of chiral xanthone derivatives may be mediated by 5-HT1A receptor and β-arrestin signalling |
| Q88867837 | The histamine H3 receptor inverse agonist pitolisant reduces body weight in obese mice |
| Q60473659 | The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: In vivo studies |
| Q57111935 | The nitric oxide/soluble cyclic guanylase/cyclic guanosine monophosphate pathway is involved in the cardiovascular effects of a novel α1- and β-adrenoceptor antagonist |
| Q44723148 | The possible mechanism of hypotensive activity of some pyrrolidin-2-one derivatives with antagonist properties at alpha1-adrenoceptors |
| Q38753164 | The role of glutamatergic, GABA-ergic, and cholinergic receptors in depression and antidepressant-like effect. |
| Q39212534 | The role of melatonin, neurokinin, neurotrophic tyrosine kinase and glucocorticoid receptors in antidepressant-like effect |
| Q38753146 | The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect |
| Q43534122 | Tissue distribution of gold nanoparticles after single intravenous administration in mice. |
| Q112246862 | Tridentate ONO ligands in vanadium(III-V) complexes - synthesis, characterization and biological activity |
| Q86999804 | α-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one |